葛兰素史克（中国）投资有限公司

一家肩负特殊使命、以科学为导向的全球医疗保健公司

我们是一家以科学为导向的全球医疗保健公司，旨在帮助人们做到更多、感觉更舒适、生活更长久。

我们在全球拥有三大业务，致力于研究、开发和制造创新的处方药、疫苗和消费保健品。

我们的目标是成为最具创新性、绩效最出色，并且值得信任的全球医疗保健公司之一。

100多年来，GSK一直致力于帮助改善中国人民的健康、生活和未来。

我们在95个国家拥有99, 000多名杰出员工，他们在科学技术、监管、知识产权和商业化等领域有着独特专长。在中国，我们拥有8,000多名员工。 

我们在中国的分布

五个区域中心：北京、成都、广州、杭州、上海

遍布中国约 250 个城市

位于北京的GSK传染病和公共卫生研究所

位于苏州的消费保健品创新中心

在中国的业务

处方药：我们的处方药业务拥有广泛的创新和成熟的产品组合。在中国，我们目前专注于以下疾病领域：呼吸系统、肝炎、神经系统疾病和HIV/艾滋病，以及包括系统性红斑狼疮在内的免疫系统疾病和包括肺动脉高压在内的罕见病。

疫苗：我们是中国市场领先的疫苗供应商，致力于提高疫苗对中国患者和消费者的可及性。我们的儿童及成人疫苗可预防多种疾病：带状疱疹疫苗、宫颈癌疫苗，以及包括成人及儿童两种剂型的乙肝病毒疫苗。

消费保健品：我们的消费保健品业务研发并销售受消费者青睐和专家推荐的品牌和创新产品组合。目前，在疼痛管理、呼吸健康、皮肤健康、营养补充剂、口腔健康五大品类拥有12个消费健康品牌，领导全球及中国非处方药产业。其中不乏舒适达、芬必得、新康泰克、百多邦、善存、钙尔奇等著名品牌。

A science-led global healthcare company with a special purpose

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

Our goal is to be one of the world’s most innovative, best performing and most trusted healthcare companies. 

Through our strong heritage, we have a legacy of over 100 years of helping to transform the health, lives, and future of people across China. 

We have over 99,000 employees across 95 countries with outstanding scientific and technical know-how and deep expertise in regulation, intellectual property and commercialization. In China, we have more than 8,000 employees.  

Our China ‘footprint’:

Five regional hubs: Beijing, Chengdu, Guangzhou, Hangzhou, Shanghai

Presence in approximately 250 cities in China

Infectious disease and public health institute in Beijing

Innovation Centre in Suzhou 

What we do in China

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.

Pharmaceuticals: Our Pharmaceutical business has a broad portfolio of innovative, established medicines with leadership positions in respiratory and HIV. In China, we focus on the following disease areas: respiratory disease, hepatitis, neurological disorders, HIV/AIDS, immunological disorders such as systemic lupus erythematosus, and rare disease such as pulmonary hypertension.

Vaccines: In China, we are one of the leading vaccines suppliers and we are dedicated to maki ng our vaccines available and accessible for people in China. Our vaccines for children and ad ults help to prevent illness by protecting against diseases, including Shingles, HPV and Hepatitis B. 

Consumer Healthcare: Our Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert recommended brands. Currently we have 12 brands leading in Pain Management, Respiratory Health, Skin Health, VMS, Oral Health categories, such as: Sensodyne, Fenbid, Contac, Bactroban, Centrum, Caltrate, etc.